Bispecific antibodies and CLEM: an analytical approach to advanced cell imaging for therapeutic strategies
Abstract The development of bispecific antibodies (BsAbs) represents a significant advancement in therapeutic antibody design, enabling the simultaneous targeting of two different antigens. This dual-targeting capability enhances therapeutic efficacy, particularly in complex diseases like cancer, wh...
Saved in:
| Main Authors: | Han-ul Kim, Young Kwan Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-01-01
|
| Series: | Applied Microscopy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42649-024-00106-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024-12-01) -
Producing and prospects for the use of bispecific antibodies for the treatment of cancer
by: S. E. Sedykh, et al.
Published: (2019-01-01) -
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
by: Alfred L. Garfall, et al.
Published: (2025-07-01) -
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
by: Baoshan Zhang, et al.
Published: (2023-12-01) -
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer
by: S. M. Greiner, et al.
Published: (2025-07-01)